CG
FOLD icon

Carmignac Gestion’s Amicus Therapeutics FOLD Stock Holding History

Carmignac Gestion’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-784,508
Closed -$11.3M – 110
2026
Q1 		$11.3M Buy
784,508
+589,621
+303% +$8.45M 0.17% 54
2025
Q4 		$2.78M Buy
+194,887
New +$1.91M 0.04% 92

Other funds holding FOLD

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Carmignac Gestion's FOLD Position: Q2 2026 in Review

Carmignac Gestion sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 784,508 shares — an estimated $11.3M sold.

Carmignac Gestion first reported a position in FOLD in Q4 2025 and held it in 2 quarters. The position peaked at $11.3M in Q1 2026. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.

  • Carmignac Gestion reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Carmignac Gestion sold 784,508 Amicus Therapeutics shares in Q2 2026, an estimated $11.3M.
  • Carmignac Gestion first reported a position in Amicus Therapeutics in Q4 2025 and held it in 2 quarters.
  • Carmignac Gestion's Amicus Therapeutics position peaked at $11.3M in Q1 2026.
  • 2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on Carmignac Gestion's 13F filing for Q2 2026, filed 13 Aug 2026.